These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 22207352)
1. Role of DNA methylation in the regulation of the RANKL-OPG system in human bone. Delgado-Calle J; Sañudo C; Fernández AF; García-Renedo R; Fraga MF; Riancho JA Epigenetics; 2012 Jan; 7(1):83-91. PubMed ID: 22207352 [TBL] [Abstract][Full Text] [Related]
2. Influence of DNA methylation on the expression of OPG/RANKL in primary osteoporosis. Wang P; Cao Y; Zhan D; Wang D; Wang B; Liu Y; Li G; He W; Wang H; Xu L Int J Med Sci; 2018; 15(13):1480-1485. PubMed ID: 30443169 [No Abstract] [Full Text] [Related]
3. The relationship between osteoclastogenic and anti-osteoclastogenic pro-inflammatory cytokines differs in human osteoporotic and osteoarthritic bone tissues. Zupan J; Komadina R; Marc J J Biomed Sci; 2012 Mar; 19(1):28. PubMed ID: 22380539 [TBL] [Abstract][Full Text] [Related]
4. OPG/RANKL/RANK gene methylation among alcohol-induced femoral head necrosis in northern Chinese men. Wang T; Wang F; Liu T; Sun M; An F; Liu C; Tian Y; Cao Y; Wang J J Orthop Surg Res; 2021 Mar; 16(1):223. PubMed ID: 33773583 [TBL] [Abstract][Full Text] [Related]
5. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157 [TBL] [Abstract][Full Text] [Related]
6. RANKL/OPG in primary cultures of osteoblasts from post-menopausal women. Differences between osteoporotic hip fractures and osteoarthritis. Giner M; Rios MA; Montoya MA; Vázquez MA; Naji L; Pérez-Cano R J Steroid Biochem Mol Biol; 2009 Jan; 113(1-2):46-51. PubMed ID: 19073256 [TBL] [Abstract][Full Text] [Related]
7. Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression. Takács I; Lazáry A; Kósa JP; Kiss J; Balla B; Nagy Z; Bácsi K; Speer G; Lakatos P Eur J Endocrinol; 2010 Feb; 162(2):423-31. PubMed ID: 19934266 [TBL] [Abstract][Full Text] [Related]
8. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238 [TBL] [Abstract][Full Text] [Related]
9. Effects of 17β-estradiol on adiponectin regulation of the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand. Wang QP; Yang L; Li XP; Xie H; Liao EY; Wang M; Luo XH Bone; 2012 Sep; 51(3):515-23. PubMed ID: 22634178 [TBL] [Abstract][Full Text] [Related]
10. Receptor activator of nuclear factor-κB ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (review). Liu W; Zhang X Mol Med Rep; 2015 May; 11(5):3212-8. PubMed ID: 25572286 [TBL] [Abstract][Full Text] [Related]
11. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis. Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Osteoprotectin (OPG)/Receptor Activator of Nuclear Factor- Luo W; Song Y; Wang J; Yang X; Li Z; Cong H Biomed Res Int; 2022; 2022():1592576. PubMed ID: 35993046 [TBL] [Abstract][Full Text] [Related]
13. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse. Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637 [TBL] [Abstract][Full Text] [Related]
14. PTH differentially regulates expression of RANKL and OPG. Huang JC; Sakata T; Pfleger LL; Bencsik M; Halloran BP; Bikle DD; Nissenson RA J Bone Miner Res; 2004 Feb; 19(2):235-44. PubMed ID: 14969393 [TBL] [Abstract][Full Text] [Related]
15. Development of a High-Throughput Screening Strategy for Upregulators of the OPG/RANKL Ratio with the Potential for Antiosteoporosis Effects. Gong S; Han X; Li X; Yang J; He X; Si S J Biomol Screen; 2016 Aug; 21(7):738-48. PubMed ID: 27301430 [TBL] [Abstract][Full Text] [Related]
16. Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG. Xu S; Zhang Y; Liu B; Li K; Huang B; Yan B; Zhang Z; Liang K; Jia C; Lin J; Zeng C; Cai D; Jin D; Jiang Y; Bai X J Bone Miner Res; 2016 Jul; 31(7):1320-33. PubMed ID: 26825871 [TBL] [Abstract][Full Text] [Related]
17. Expression of RANKL/OPG during bone remodeling in vivo. Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583 [TBL] [Abstract][Full Text] [Related]
18. DNA methylation in the OPG/RANK/RANKL pathway is associated with steroid-induced osteonecrosis of the femoral head. Sun M; Cao Y; Yang X; An F; Wu H; Wang J BMC Musculoskelet Disord; 2021 Jun; 22(1):599. PubMed ID: 34187427 [TBL] [Abstract][Full Text] [Related]
19. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin. Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296 [TBL] [Abstract][Full Text] [Related]
20. Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. Li M; Yang S; Xu D J Biol Chem; 2016 Nov; 291(46):24160-24171. PubMed ID: 27697839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]